1-90937883-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_201269.3(ZNF644):c.3290A>G(p.Asn1097Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,613,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_201269.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF644 | NM_201269.3 | c.3290A>G | p.Asn1097Ser | missense_variant | 4/6 | ENST00000337393.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF644 | ENST00000337393.10 | c.3290A>G | p.Asn1097Ser | missense_variant | 4/6 | 1 | NM_201269.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000887 AC: 135AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000187 AC: 47AN: 250826Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135550
GnomAD4 exome AF: 0.0000759 AC: 111AN: 1461624Hom.: 0 Cov.: 33 AF XY: 0.0000509 AC XY: 37AN XY: 727112
GnomAD4 genome ? AF: 0.000887 AC: 135AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000900 AC XY: 67AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.3290A>G (p.N1097S) alteration is located in exon 4 (coding exon 3) of the ZNF644 gene. This alteration results from a A to G substitution at nucleotide position 3290, causing the asparagine (N) at amino acid position 1097 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ZNF644-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 13, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at